What to watch with Glukose and menopause?

Menopause involves hormonal shifts that can impact glucose metabolism: declining estrogen is linked to increased insulin resistance, altered fat distribution, and higher risk of impaired glucose tolerance. Many consumer DNA tests offer SNPs such as TCF7L2, GCK, or PPARG, which are associated with fasting glucose or type 2 diabetes. However, effect sizes are typically small (odds ratios < 1.3) and individual predictive value is low. Evidence comes mostly from GWAS, not interventional trials. Lifestyle factors—exercise, low-glycemic diet, weight management, and regular blood glucose monitoring—are far more impactful than any single genetic marker. Gut microbiome composition may also modulate glucose response, but commercial tests lack diagnostic validity. No test should replace medical advice; during menopause, clinical assessment of hormone status and metabolic risk is essential. The provided context does not contain direct studies on glucose and menopause, so the evidence level is marked as unclear.